Literature DB >> 23427517

Congenital central hypoventilation syndrome with hirschsprung's disease due to PHOX2B gene mutation in a Turkish infant.

Aytekin Kaymakçi1, Fatma Narter, Ahmet Sami Yazar, Müberra Seğmen Yilmaz.   

Abstract

The association of congenital central hypoventilation syndrome (also known as Ondine's curse) and Hirschsprung's disease is termed Haddad syndrome, which is an extremely rare disorder. Recent studies have described that the PHOX2B gene mutation was responsible for congenital central hypoventilation syndrome. We report a term newborn male infant with clinical manifestations of recurrent hypoventilation with hypercapnia and bowel obstructions. These clinical manifestations were compatible with congenital central hypoventilation syndrome and Hirschsprung's disease. PHOXB direct sequencing showed a heterozygous in-frame duplication of 21 bp leading to an expansion of +7 alanines within the 20 alanine stretch of the PHOX2B gene and confirmed our diagnosis. In addition to a high index of clinical suspicion, testing for PHOX2B mutation can assist iq the diagnosis of congenital central hypoventilation syndrome and in the prediction of disease progression. Infants presenting with congenital central hypoventilation syndrome should also be screened for Hirschsprung's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23427517

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  2 in total

1.  Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Authors:  Jian Wang; Hao Du; Ya-Ru Mou; Jian-Yi Niu; Wen-Tong Zhang; Hong-Chao Yang; Ai-Wu Li
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Abundance and Significance of Neuroligin-1 and Neurexin II in the Enteric Nervous System of Embryonic Rats.

Authors:  Dongming Wang; Jingnian Pan; Guoxin Song; Ni Gao; Yi Zheng; Qiangye Zhang; Aiwu Li
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.